In-vivo activation of circulating inactive renin by the ischemic kidney in man. 1982

N Glorioso, and P Madeddu, and P D Fulgheri, and F Cocco, and G Sanna, and C Fiori, and S Dettori, and A Rappelli

The role of the kidney as a possible source or as activator of inactive renin was studied in 22 patients with Essential Hypertension (EH) and in 20 patients with Unilateral Renal Artery Stenosis (RAS). Active and inactive renin (trypsin activation) were measured in blood samples taken simultaneously from both renal veins and from a peripheral artery during acute diuretic stimulation induced by furosemide 40 mg i.v. In EH pts active and trypsin-activated renin were significantly higher in both renal veins than in arterial blood (P less than 0.001 and P less than 0.02 respectively) whereas no difference was seen as far as inactive renin is concerned. In unilateral RAS trypsin-activated and active renin from the ischemic kidney were significantly higher (P less than 0.01 and P less than 0.005 respectively) while inactive renin was significantly lower (P less than 0.005) than in arterial blood. No significant difference was seen between arterial and renal venous blood from the contralateral kidney as far as active and inactive renin are concerned. When comparing the V-A differences for active renin to the corresponding V-A differences for inactive renin from the ischemic kidney a significant negative correlation appeared (r = -0.49 p less than 0.05) whereas no correlation was found from the contralateral kidney (r = -0.26 n.s.). These data demonstrate that the ischemic kidney, in addition to its ability to release active renin, can also activate circulating inactive renin.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D006977 Hypertension, Renal Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN. Hypertensions, Renal,Renal Hypertension,Renal Hypertensions
D006978 Hypertension, Renovascular Hypertension due to RENAL ARTERY OBSTRUCTION or compression. Hypertension, Goldblatt,Goldblatt Syndrome,Goldblatt Hypertension,Renovascular Hypertension,Syndrome, Goldblatt
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012077 Renal Artery A branch of the abdominal aorta which supplies the kidneys, adrenal glands and ureters. Arteries, Renal,Artery, Renal,Renal Arteries
D012078 Renal Artery Obstruction Narrowing or occlusion of the RENAL ARTERY or arteries. It is due usually to ATHEROSCLEROSIS; FIBROMUSCULAR DYSPLASIA; THROMBOSIS; EMBOLISM, or external pressure. The reduced renal perfusion can lead to renovascular hypertension (HYPERTENSION, RENOVASCULAR). Renal Artery Stenosis,Obstruction, Renal Artery,Obstructions, Renal Artery,Renal Artery Obstructions,Renal Artery Stenoses,Stenoses, Renal Artery,Stenosis, Renal Artery
D012082 Renal Veins Short thick veins which return blood from the kidneys to the vena cava. Renal Vein,Vein, Renal,Veins, Renal
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive

Related Publications

N Glorioso, and P Madeddu, and P D Fulgheri, and F Cocco, and G Sanna, and C Fiori, and S Dettori, and A Rappelli
February 1979, Clinical science (London, England : 1979),
N Glorioso, and P Madeddu, and P D Fulgheri, and F Cocco, and G Sanna, and C Fiori, and S Dettori, and A Rappelli
January 1987, Agents and actions. Supplements,
N Glorioso, and P Madeddu, and P D Fulgheri, and F Cocco, and G Sanna, and C Fiori, and S Dettori, and A Rappelli
March 1983, The Journal of clinical investigation,
N Glorioso, and P Madeddu, and P D Fulgheri, and F Cocco, and G Sanna, and C Fiori, and S Dettori, and A Rappelli
November 1983, Horumon to rinsho. Clinical endocrinology,
N Glorioso, and P Madeddu, and P D Fulgheri, and F Cocco, and G Sanna, and C Fiori, and S Dettori, and A Rappelli
July 1983, Clinical science (London, England : 1979),
N Glorioso, and P Madeddu, and P D Fulgheri, and F Cocco, and G Sanna, and C Fiori, and S Dettori, and A Rappelli
November 1979, The Journal of clinical endocrinology and metabolism,
N Glorioso, and P Madeddu, and P D Fulgheri, and F Cocco, and G Sanna, and C Fiori, and S Dettori, and A Rappelli
January 1979, Circulation research,
N Glorioso, and P Madeddu, and P D Fulgheri, and F Cocco, and G Sanna, and C Fiori, and S Dettori, and A Rappelli
December 1979, Clinical science (London, England : 1979),
N Glorioso, and P Madeddu, and P D Fulgheri, and F Cocco, and G Sanna, and C Fiori, and S Dettori, and A Rappelli
August 1987, Nihon Jinzo Gakkai shi,
N Glorioso, and P Madeddu, and P D Fulgheri, and F Cocco, and G Sanna, and C Fiori, and S Dettori, and A Rappelli
June 1990, Nihon Naibunpi Gakkai zasshi,
Copied contents to your clipboard!